PPT-Antineoplastic agents Pharmaceutical chemistry

Assist Prof Karima F Ali Almustansiriyah university college of pharmacy The ability of drugs to kill cancer cells is generally believed to be because of their ability to induce the process of apoptosis In highdose therapy cell death may occur by necrosis but this is also toxic to the patient In a general sense the anti neoplastics target DNA or the process of DNA replication and stimulate apoptosis but the exact mechanisms by which this stimulation occurs are not known with certainty. University of California at San Francisco, 1700 4th Street, San Francisco, CA 94158-2330, USA. tel: +1 415 514 4227; fax: +1 415 514 423 lted in models of useful accuracy for domains in more than ha Ofelia Chernock, . Portfolio Marketing Manager. Information Resources to Facilitate . and Optimize Pharmacology, Toxicology . and Pharmaceutical Science Research. Agenda. The Value of Content to Facilitate Pharmacology, Toxicology and . Pharmacology I. NURS 1950. 1. Objective 1: Describe the general factors utilized to select the therapy used to treat cancer. 2. Objective 2: Describe the general uses of chemotherapy in the treatment of cancer. Antineoplastic agents. Antineoplastic agents are drugs used for the treatment of cancer, malignancy, tumor, carcinoma, sarcoma, . Leukemia, or neoplasm (Greek neo = new, Plasm = formation). Neoplasm refers to a group of diseases caused by several agents, namely, chemical compounds and radiant energy. . Adrenergic . Agents. Assist . Prof . Karima F. Ali. AL-Mustansiriyah university. College of pharmacy. Adrenergic drugs. . exert their principal pharmacological . and therapeutic . effects by either enhancing or reducing . BP 602 T Pharmacology III. Neoplastic disease . Cancer is a disease . characterised. by uncontrolled multiplication and spread of abnormal forms of the body's own cells. . The terms . cancer. , . malignant neoplasm. Non living matter and minerals found on earth. The distinction between the organic and inorganic are not . a. bsolute ,but there is much overlap.. It has many applications in every aspect of pharmacy including catalysis in drug synthesis, pigments, surfactants and agriculture. . M.Pharm. (Ph.D.). Associate Professor. DEPARTMENT OF PHARMACEUTICAL CHEMISTRY. . INTRODUCTION. Also known as . cardiac dysrhythmia . medications.. These are the drugs that are used to . M. rs. .SASHMITHA SAMUEL. . M.P. harm. . (Ph.D.). . Associate Professor. DEPARTMENT OF PHARMACEUTICAL CHEMISTRY. 2. DEPARTMENT OF PHARMACEUTICAL CHEMISTRY. BLOOD. It . By . S . S. D BHAVANI RAJA. ASSISTANT PROFESSOR . DEPARTMENT. OF . PHARMACEUTICAL CHEMISTRY. Sources of Impurities. Department of Pharmaceutical Chemistry. Sources of Impurities. Impurity:-. Any substance coexisting with the original drug such as starting material or intermediate or that is formed due to any side reactions..  . UNIT III. HETEROCYCLIC COMPOUNDS. Synthesis , reactions and Medicinal uses of . FURAN. Department of Pharmaceutics. Preservatives are substances that are commonly added to various foods and pharmaceutical products in order to prolong their shelf life.. Preservatives. . 1. Non-irritant.. Microbiological quality of pharmaceutical products is influenced by:. Environment . Materials . . Good Manufacturing Practices (GMP). It is developed to minimize contamination by a study:. Ecology of microorganisms. Toxics . Release Inventory to Assess Implementation and Impact of . Green . Chemistry Practices by the Pharmaceutical Manufacturing . Sector. Stephen . C. DeVito, Ph.D., . R.Ph. .. Toxics Release Inventory Program.